Due to health issues, this site is no longer maintained and will be shut down shortly.

VRNA Verona Pharma plc ADRs

Verona Pharma PLC develops drugs for respiratory diseases. Its products mainly include anti-inflammatory agents and bronchodilators. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:VRP.

$20.72  +0.09 (0.44%)
As of 03/27/2023 11:51:06 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  United Kingdom
Country of incorporation:  United Kingdom
IPO date:  04/27/2017
Outstanding shares:  51,818,198
Average volume:  513,805
Market cap:   $1,028,591,230
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      BYWPZK5
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy